Lexston Life Sciences Corp.(TSE:LEXT)
CA$0.04-0.00 (-12.50%)
TSE:LEXT
Lexston Life Sciences Corp. financials statements
CA$0.04
At close:-0.00 (-12.50%)
Want to see TSE:LEXT full AI Analyst Report?
Lexston Life Sciences Corp. (LEXT) Ratios
6 Followers
Lexston Life Sciences Corp. Ratios
TSE:LEXT's free cash flow for Q4 2026 was C$-148.38K. For the 2026 fiscal year, TSE:LEXT's free cash flow was decreased by C$-5.00 and operating cash flow was C$-148.38K. See a summary of the company’s cash flow.
| Ratios | Aug 26 | Aug 25 | Aug 24 | May 23 | Aug 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.96 | 0.80 | 11.37 | 67.61 | 10.31 |
| Quick Ratio | 1.96 | 0.80 | 11.37 | 67.61 | 10.31 |
| Cash Ratio | 0.85 | 0.01 | 9.79 | 45.60 | 7.47 |
| Solvency Ratio | -9.54 | -7.62 | -21.10 | -96.27 | -28.93 |
| Operating Cash Flow Ratio | -7.40 | -5.71 | -13.12 | -88.14 | -17.72 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | C$ 143.64K | C$ -41.83K | C$ 413.59K | C$ 746.46K | C$ 736.36K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.20 | 3.95 | 1.06 | 1.01 | 1.09 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.09 | 0.00 | 0.60 | 0.61 | 0.26 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 66.89% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | -642.70% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | -633.84% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | -553.89% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | -642.70% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | -642.70% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | -642.70% |
| Net Income Per EBT | 105.14% | 104.96% | 118.17% | 114.77% | 100.00% |
| EBT Per EBIT | 100.00% | 114.49% | 108.83% | 110.85% | 116.03% |
| Return on Assets (ROA) | -159.75% | -578.49% | -115.55% | -136.16% | -243.52% |
| Return on Equity (ROE) | -191.87% | -2287.81% | -122.03% | -138.06% | -265.56% |
| Return on Capital Employed (ROCE) | -182.49% | -1903.88% | -94.89% | -108.52% | -228.87% |
| Return on Invested Capital (ROIC) | -182.49% | -1903.91% | -94.89% | -108.52% | -228.87% |
| Return on Tangible Assets | -159.75% | -578.49% | -115.55% | -136.16% | -243.52% |
| Earnings Yield | -194.51% | -170.07% | -25.58% | -42.25% | -346.44% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 9.61 |
| Payables Turnover | 0.00 | 0.00 | 0.66 | 2.66 | 1.66 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 3.33 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.38 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.43 |
| Cash Conversion Cycle | 0.00 | 0.00 | -551.34 | -137.27 | -182.40 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 37.98 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 551.34 | 137.27 | 220.38 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 37.98 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.06 | -0.25 | -0.14 | -0.30 | -1.26 |
| Free Cash Flow Per Share | -0.06 | -0.25 | -0.19 | -0.30 | -1.26 |
| Dividend Paid and CapEx Coverage Ratio | -276121.00 | 0.00 | -2.62 | 0.00 | -3229.15 |
| Capital Expenditure Coverage Ratio | -276121.00 | 0.00 | -2.62 | 0.00 | -3229.15 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -3.88 |
| Free Cash Flow Yield | -150.89% | -125.46% | -21.32% | -37.64% | -209.32% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.51 | -0.59 | -3.91 | -2.37 | -0.29 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 1.86 |
| Price-to-Book (P/B) Ratio | 0.99 | 13.45 | 4.77 | 3.27 | 0.77 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.66 | -0.80 | -4.69 | -2.66 | -0.48 |
| Price-to-Operating Cash Flow Ratio | -0.66 | -0.80 | -6.48 | -2.66 | -0.48 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | -0.02 | 0.12 | 0.03 | -0.00 |
| Enterprise Value Multiple | -0.45 | -0.63 | -4.63 | -2.51 | -0.03 |
| Enterprise Value | 605.45K | 948.35K | 3.00M | 2.11M | 79.24K |
| EV to EBITDA | -0.45 | -0.63 | -4.63 | -2.51 | -0.03 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.22 |
| EV to Free Cash Flow | -0.55 | -0.80 | -4.15 | -2.14 | -0.06 |
| EV to Operating Cash Flow | -0.55 | -0.80 | -5.74 | -2.14 | -0.06 |
| Tangible Book Value Per Share | 0.04 | 0.01 | 0.19 | 0.24 | 0.78 |
| Shareholders’ Equity Per Share | 0.04 | 0.01 | 0.19 | 0.24 | 0.78 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.32 |
| Net Income Per Share | -0.08 | -0.34 | -0.23 | -0.34 | -2.08 |
| Tax Burden | 1.05 | 1.05 | 1.18 | 1.15 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.09 | 1.11 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.35 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 4.56 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 1.96 |
| Income Quality | 0.82 | 0.77 | 0.60 | 0.89 | 0.60 |
Currency in CAD

